Palisade Bio (PALI) Enterprise Value (2010 - 2026)
Palisade Bio (PALI) reported Enterprise Value of -$129.6 million for Q1 2026, down 1692.12% year-over-year from $8.1 million in Q1 2025, and up 2.14% on a QoQ basis from -$132.4 million in Q4 2025.
Palisade Bio (PALI) has 17 years of Enterprise Value data on file, last reported at -$129.6 million in Q1 2026.
- Quarterly Enterprise Value fell 1692.12% year-over-year to -$129.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$129.6 million (down 1692.12% YoY) and the FY2025 annual result came in at -$132.4 million, down 1256.13% from the prior year.
- Enterprise Value improved to -$129.6 million in Q1 2026 per PALI's latest filing, from -$132.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$5.0 million in Q2 2022 and bottomed at -$132.4 million in Q4 2025.
- The 5-year median for Enterprise Value is -$11.4 million (2024), against an average of -$24.5 million.
- The widest annual swing landed in 2022, when Enterprise Value surged 60.64%; it then slumped 1692.12% in 2026.
- Tracing PALI's Enterprise Value over 5 years: stood at -$12.4 million in 2022, then slipped by 0.4% to -$12.4 million in 2023, then rose by 21.47% to -$9.8 million in 2024, then tumbled by 1256.13% to -$132.4 million in 2025, then rose by 2.14% to -$129.6 million in 2026.
- Per Business Quant, the three latest PALI Enterprise Value figures stand at -$129.6 million (Q1 2026), -$132.4 million (Q4 2025), and -$5.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | -129.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.57 Mn |
| Dec 31, 2025 | -132.40 Mn |
| Sep 30, 2025 | -5.23 Mn |
| Jun 30, 2025 | -5.42 Mn |
| Mar 31, 2025 | -7.23 Mn |
| Dec 31, 2024 | -9.76 Mn |
| Sep 30, 2024 | -8.04 Mn |
| Jun 30, 2024 | -11.35 Mn |
| Mar 31, 2024 | -11.28 Mn |
| Dec 31, 2023 | -12.43 Mn |
| Sep 30, 2023 | -15.31 Mn |
| Jun 30, 2023 | -16.40 Mn |
| Mar 31, 2023 | -13.30 Mn |
| Dec 31, 2022 | -12.38 Mn |
| Sep 30, 2022 | -13.99 Mn |
| Jun 30, 2022 | -4.98 Mn |
| Mar 31, 2022 | -6.64 Mn |
| Dec 31, 2021 | -10.50 Mn |
| Sep 30, 2021 | -14.10 Mn |
| Jun 30, 2021 | -12.65 Mn |
| Mar 31, 2021 | -615,000.00 |
| Dec 31, 2020 | -713,000.00 |
| Sep 30, 2020 | -751,000.00 |
| Jun 30, 2020 | -1.52 Mn |
| Mar 31, 2020 | -10.03 Mn |
| Dec 31, 2019 | -5.11 Mn |
| Sep 30, 2019 | -7.30 Mn |
| Jun 30, 2019 | -2.28 Mn |
| Mar 31, 2019 | -4.01 Mn |
| Dec 31, 2018 | -5.79 Mn |
| Sep 30, 2018 | -5.74 Mn |
| Jun 30, 2018 | -7.09 Mn |
| Mar 31, 2018 | -9.72 Mn |
| Dec 31, 2017 | -11.67 Mn |
| Sep 30, 2017 | -14.06 Mn |
| Jun 30, 2017 | -11.44 Mn |
| Mar 31, 2017 | -16.68 Mn |
| Dec 31, 2016 | -20.19 Mn |
| Sep 30, 2016 | -5.68 Mn |
| Jun 30, 2016 | -11.13 Mn |
| Mar 31, 2016 | -7.62 Mn |
| Dec 31, 2015 | -12.23 Mn |
| Sep 30, 2015 | -18.15 Mn |
| Jun 30, 2015 | -23.68 Mn |
| Mar 31, 2015 | -28.63 Mn |
| Dec 31, 2014 | -27.53 Mn |
| Sep 30, 2014 | -26.95 Mn |
| Jun 30, 2014 | -30.23 Mn |
| Mar 31, 2014 | -33.34 Mn |
| Dec 31, 2013 | -16.85 Mn |
| Sep 30, 2013 | -16.40 Mn |
| Jun 30, 2013 | -11.17 Mn |
| Mar 31, 2013 | -12.66 Mn |
| Dec 31, 2012 | -7.44 Mn |
| Sep 30, 2012 | -9.87 Mn |
| Jun 30, 2012 | -2.54 Mn |
| Mar 31, 2012 | -5.14 Mn |
| Dec 31, 2011 | -2.35 Mn |
| Sep 30, 2011 | -4.20 Mn |
| Jun 30, 2011 | -6.14 Mn |
| Mar 31, 2011 | -8.55 Mn |
| Dec 31, 2010 | -9.26 Mn |
| Sep 30, 2010 | -11.59 Mn |
| Jun 30, 2010 | -14.03 Mn |